As many as 53.54 lakh equity shares of Bayer Crop Sciences Ltd. changed hands in a large transaction that took place in the pre-open block window on Wednesday, July 8. According to reports from CNBC TV18, the number of shares that changed hands represents 11.91% of the company's outstanding equity. The transaction was executed at an average price of ₹4,122 per share, bringing the total transaction value to ₹2,207 crore. The identities of buyers and sellers in the block deal remain undisclosed at this time. The company operates across crop protection, seeds and traits, and digital farming segments, making it a key player in India's agricultural solutions market.
Shares of Bayer Crop Sciences experienced significant volatility on Wednesday, jumping as much as 5% to a day's high of ₹4,303.15 before paring some gains. As per CNBC TV18, the stock opened sharply higher and climbed to its day's peak in early trade following the large transaction. However, the stock gave up a significant portion of its gains as the session progressed. At around 9:31 a.m., Bayer Crop Sciences shares were trading 1.35% higher at ₹4,172.65 on BSE, demonstrating continued positive momentum despite the initial decline from the day's peak. The positive initial reaction reflects strong investor interest in the significant institutional transaction despite the stock's eventual decline.
At the end of the March quarter, promoters of Bayer Crop Sciences held a 71.43% stake in the company, according to data from CNBC TV18. The promoter structure includes multiple entities: Bayer Vapi Pvt. Ltd. (17.89%), Bayer Investments India Pvt. Ltd. (15.04%), Bayer Sas (14.73%), Bayer Cropscience (11.91%), Bayer AG (8.43%), and Monsanto (3.44%). Among public shareholders, Mutual Funds of India held a 9.05% stake as of March 31, 2026, with Quant Small Cap Fund (2.31%), Nippon India Small Cap Fund (1.2%), Aditya Birla Sun Life Largecap Fund (1.2%), and Bandhan Elss Tax Saver Fund (1.15%) among the prominent names. As of Q4 FY26, Foreign Institutional Investors increased their holding to 3.89% from 3.49%, while Domestic Institutional Investors raised their stake to 11.89% from 11.56%, as reported by Trade Brains.
Insurance companies maintained a 2.3% stake in the company, while nearly 52,000 small retail shareholders with authorized share capital of up to ₹2 lakh held a 7.81% stake, as reported by CNBC TV18. This retail participation demonstrates the company's broad-based ownership structure across different investor categories, with small retail investors representing a significant portion of the company's shareholder base. Block deals typically involve large quantities of shares traded between institutional or major investors through a separate trading window, which can lead to sharp movements in a stock when a sizeable portion of the company's equity changes hands.
Kotak Institutional Equities has issued a 'Add' rating on Bayer Crop Sciences with a target price of ₹4,820, while Antique Stock Broking maintains a 'Hold' rating with a target of ₹4,900. According to Kotak Institutional Equities' Q1 results preview note, Bayer's Q1FY27 results will be weighed down by the late arrival of monsoon rains as well as a shift in farmer sentiment away from corn hybrid seeds, which typically account for around a quarter of Q1 revenues. The brokerage projects a 5% YoY decline in revenues and 2.3% YoY decline in EBITDA, assuming a slight recovery in margins versus the depressed base of last year, with net income declining 7.7% YoY. The company demonstrated strong financial performance in Q4 FY26, with revenue from operations of ₹1,101 crore, compared to ₹1,046 crore in Q4 FY25, registering a 5.3% YoY growth.
